Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
In Vitro Cellular & Developmental Biology. Animal|November 17, 2009
Establishment and characterization of an osteopontin-null cutaneous squamous cell carcinoma cell lineYu-Hua Hsieh, M Margaret Juliana, Pi-Ling Chang
The Journal of Urology|February 23, 2010
Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacyRonald A Lubet, Vernon E Steele, M Margaret Juliana, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Short-term modulation of cell proliferation and apoptosis and preventive/therapeutic efficacy of various agents in a mammary cancer modelKonstantin Christov, Clinton J Grubbs, Anne Shilkaitis, et al.
International Journal of Cancer|August 21, 2008
Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancersRonald A Lubet, Susan M Fischer, Vernon E Steele, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 7, 2009
Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesisRonald A Lubet, Daniel Boring, Vernon E Steele, et al.
Cancer Research|July 20, 2006
Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontinYu-Hua Hsieh, M Margaret Juliana, Patricia H Hicks, et al.
Bladder Cancer (Amsterdam, Netherlands)|July 12, 2024
Efficacy of EGFR Inhibitors and NSAIDs Against Basal Bladder Cancers in a Rat Model: Daily vs. Weekly Dosing, Combining EGFR Inhibitors with Naproxen, and Effects on RNA ExpressionRonald A Lubet, Amit Kumar, Jennifer T Fox, et al.
Oncology Reports|May 24, 2008
Effect of cranberry juice concentrate on chemically-induced urinary bladder cancersJeevan K Prasain, Kenneth Jones, Ray Moore, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 7, 2016
5MeCDDO Blocks Metabolic Activation but not Progression of Breast, Intestine, and Tongue Cancers. Is Antioxidant Response Element a Prevention Target?Ronald A Lubet, Reid Townsend, Margie L Clapper, et al.
Oncology Reports|January 14, 2004
Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer preventionMark B Cope, Vernon E Steele, Ronald A Lubet, et al.
Pageof 3